พันธบัตร
ด้านล่างคือรายการของหุ้นกู้ GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs นักลงทุนมักเลือกใช้หุ้นกู้ของบริษัทเพื่อเพิ่มเสถียรภาพในช่วงเวลาที่ตลาดผันผวน ศึกษาราคา อัตราผลตอบแทน และสถิติอื่นๆ และค้นหาการลงทุนที่เชื่อถือได้
สัญลักษณ์ | YTM % | ปริมาณการซื้อขาย | ราคา % | ดอกเบี้ย % | วันครบกำหนดอายุ | ยอดคงค้าง | มูลค่าหน้าตั๋ว | จำนวนเงินขั้นต่ำ | ผู้ออก |
|---|---|---|---|---|---|---|---|---|---|
| XXS86659697GlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | 5.72% | 0 | 82.57% | 4.250% | 2045-12-18 | 370.79 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| XXS29462437GlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | 5.61% | 0 | 96.09% | 5.250% | 2042-04-10 | 477.82 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| XXS35082093GlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | 5.44% | 0 | 108.66% | 6.375% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGX4CGlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5.18% | 0 | 88.78% | 4.200% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | 4.99% | 0 | 74.89% | 1.625% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AE7GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 4.92% | 0 | 113.52% | 6.375% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377372AQ0GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | 4.61% | 0 | 101.96% | 4.875% | 2035-04-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS14051686GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | 4.55% | 0 | 104.70% | 5.250% | 2033-12-19 | 574.17 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AB3GlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | 4.46% | 0 | 106.35% | 5.375% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS86658852GlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | 4.11% | 0 | 98.53% | 3.375% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AP2GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | 4.06% | 0 | 101.78% | 4.500% | 2030-04-15 | 850 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | 3.98% | 0 | 92.49% | 1.250% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | 3.95% | 0 | 98.08% | 3.375% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | 3.88% | 0 | 100.00% | 3.875% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AM7GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | 3.79% | 0 | 100.71% | 4.315% | 2027-03-12 | 400 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | 3.48% | 0 | 97.88% | 3.250% | 2036-11-19 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | 3.09% | 0 | 100.18% | 3.125% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | 2.98% | 0 | 99.42% | 2.875% | 2031-11-19 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | 2.75% | 0 | 95.76% | 1.750% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | 2.61% | 0 | 95.49% | 1.375% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | 2.39% | 0 | 101.23% | 3.000% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | 2.24% | 0 | 99.44% | 1.250% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | 2.19% | 0 | 98.97% | 1.000% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 1.48 M | 100.35% | 4.727% | 2027-03-12 | 600 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0.883% | 2028-09-21 | 42.5 B JPY | 100,000,000.00 JPY | 100,000,000.00 JPY | GlaxoSmithKline Capital Plc |